149 related articles for article (PubMed ID: 37533546)
1. Kidney dysfunction due to AA amyloidosis in a morbidly obese female.
Izzedine H; Nimkar A; Bharati J; Brocheriou I; Mathian A; Charlotte F; Jhaveri KD; Georgin-Lavialle S
Clin Nephrol Case Stud; 2023; 11():121-125. PubMed ID: 37533546
[TBL] [Abstract][Full Text] [Related]
2. Renal AA amyloidosis secondary to morbid obesity?
Alsina E; Martin M; Panadés M; Fernández E
Clin Nephrol; 2009 Oct; 72(4):312-4. PubMed ID: 19825338
[TBL] [Abstract][Full Text] [Related]
3. Serum Amyloid A Protein-Associated Kidney Disease: Presentation, Diagnosis, and Management.
Thorne J; Clark D; Geldenhuys L; More K; Vinson A; Tennankore K
Kidney Med; 2022 Aug; 4(8):100504. PubMed ID: 35879979
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report.
Seneschall C; Law S; Roufosse C; Woodham S; Kousios A
J Nephrol; 2024 Jan; ():. PubMed ID: 38206475
[TBL] [Abstract][Full Text] [Related]
5. Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor.
Agha I; Mahoney R; Beardslee M; Liapis H; Cowart RG; Juknevicius I
Am J Kidney Dis; 2002 Aug; 40(2):411-5. PubMed ID: 12148117
[TBL] [Abstract][Full Text] [Related]
6. Sickle cell disease: a case report of renal amyloidosis.
Bugeja A; Blanco P; Clark EG; Sood MM
BMC Nephrol; 2018 Oct; 19(1):256. PubMed ID: 30305036
[TBL] [Abstract][Full Text] [Related]
7. Amyloid A amyloidosis with subcutaneous drug abuse.
Mendoza JM; Peev V; Ponce MA; Thomas DB; Nayer A
J Renal Inj Prev; 2014; 3(1):11-6. PubMed ID: 25340157
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer of the uterus complicated by renal AA amyloidosis.
Fujisawa H; Ohashi A; Ohta J; Muraki N; Nakano Y; Sugita K; Ishihara S; Kumagai J; Fukutomi T; Nagahama K
CEN Case Rep; 2021 Feb; 10(1):115-120. PubMed ID: 32910374
[TBL] [Abstract][Full Text] [Related]
9. [Systemic AA amyloidosis induced by benign neoplasms].
Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma.
Nalcacioglu H; Ozkaya O; Genc G; Ayyildiz S; Kefeli M; Elli M; Aydin O; Ceyhan Bilgici M
Int J Rheum Dis; 2018 Feb; 21(2):552-559. PubMed ID: 29239128
[TBL] [Abstract][Full Text] [Related]
11. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
[TBL] [Abstract][Full Text] [Related]
12. [Secondary (AA) amyloidosis in Crohn's disease].
Bulum T; Prkacin I; Cavrić G; Sobocan N; Skurla B; Duvnjak L; Bulimbasić S
Acta Med Croatica; 2011; 65(3):271-8. PubMed ID: 22359896
[TBL] [Abstract][Full Text] [Related]
13. Unknown aspect of the old disease: does dyslipidemia in systemic AA amyloidosis differ from the dyslipidemia in primary glomerulonephritis?
Piskinpasa S; Agbaht K; Akoglu H; Akyel F; Ozkayar N; Yenigun Coskun E; Turgut D; Koc E; Odabas AR; Dede F
Ren Fail; 2015; 37(8):1273-9. PubMed ID: 26181645
[TBL] [Abstract][Full Text] [Related]
14. Turkish experience in rheumatoid arthritis patients with clinical apparent amyloid deposition.
Pamuk ON; Donmez S; Pamuk GE; Puyan FO; Keystone EC
Amyloid; 2013 Dec; 20(4):245-50. PubMed ID: 24106838
[TBL] [Abstract][Full Text] [Related]
15. A rare cause of AA amyloidosis: Glomus tumor and treatment with anakinra-Case report and literature review.
Tastekin F; Kerim D; Sen S; Kabasakal Y
Int J Rheum Dis; 2024 Jan; 27(1):e14984. PubMed ID: 38014450
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
[TBL] [Abstract][Full Text] [Related]
17. Systemic Amyloidosis in a Patient With Familial Mediterranean Fever and Hodgkin Lymphoma: A Case Report.
Demir F; Bahadir A; Mungan S; Çobanoğlu Ü; Kalyoncu M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):234-237. PubMed ID: 31094904
[TBL] [Abstract][Full Text] [Related]
18. Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience.
Erdogmus S; Kendi Celebi Z; Akturk S; Kumru G; Duman N; Ates K; Erturk S; Nergizoglu G; Kutlay S; Sengul S; Keven K
Amyloid; 2018 Jun; 25(2):115-119. PubMed ID: 29775082
[TBL] [Abstract][Full Text] [Related]
19. Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis.
Magro-Checa C; Navas-Parejo Casado A; Borrego-García E; Raya-Álvarez E; Rosales-Alexander JL; Salvatierra J; Caballero-Morales T; Gómez-Morales M
Amyloid; 2011 Dec; 18(4):235-9. PubMed ID: 21992511
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A renal amyloidosis in a chronic subcutaneous ("skin popping") heroin user.
Cooper C; Bilbao JE; Said S; Alkhateeb H; Bizet J; Elfar A; Davalos O; Meza AT; Hernandez GT
J Nephropathol; 2013 Jul; 2(3):196-200. PubMed ID: 24475449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
